209 related articles for article (PubMed ID: 30788532)
1. Clinical value of FDG-PET/CT in bacteremia of unknown origin with catalase-negative gram-positive cocci or Staphylococcus aureus.
Brøndserud MB; Pedersen C; Rosenvinge FS; Høilund-Carlsen PF; Hess S
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1351-1358. PubMed ID: 30788532
[TBL] [Abstract][Full Text] [Related]
2.
Berrevoets MAH; Kouijzer IJE; Aarntzen EHJG; Janssen MJR; De Geus-Oei LF; Wertheim HFL; Kullberg BJ; Oever JT; Oyen WJG; Bleeker-Rovers CP
J Nucl Med; 2017 Sep; 58(9):1504-1510. PubMed ID: 28336786
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia.
Vos FJ; Bleeker-Rovers CP; Sturm PD; Krabbe PF; van Dijk AP; Cuijpers ML; Adang EM; Wanten GJ; Kullberg BJ; Oyen WJ
J Nucl Med; 2010 Aug; 51(8):1234-40. PubMed ID: 20660384
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein levels can predict positive
Tsai HY; Lee MH; Wan CH; Yang LY; Yen TC; Tseng JR
J Microbiol Immunol Infect; 2018 Dec; 51(6):839-846. PubMed ID: 30190232
[TBL] [Abstract][Full Text] [Related]
5. Evidence of Clinical Impact Supports a New Petition for Medicare Coverage of 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in the Evaluation of Staphylococcus aureus Bacteremia: A Focused Literature Review and Call to Action.
Thottacherry E; Cortés-Penfield NW
Clin Infect Dis; 2022 Oct; 75(8):1457-1461. PubMed ID: 35535794
[TBL] [Abstract][Full Text] [Related]
6.
Berrevoets MAH; Kouijzer IJE; Slieker K; Aarntzen EHJG; Kullberg BJ; Oever JT; Bleeker-Rovers CP
J Nucl Med; 2019 Jul; 60(7):998-1002. PubMed ID: 30552202
[TBL] [Abstract][Full Text] [Related]
7. Impact of
Suanzes P; Willekens R; Puig-Asensio M; Pizzi MN; Roque A; Barios M; Simó M; Rodríguez-Pardo D; Larrosa MN; Fernández-Hidalgo N; Almirante B
Enferm Infecc Microbiol Clin (Engl Ed); 2023 Jan; 41(1):3-10. PubMed ID: 36319538
[TBL] [Abstract][Full Text] [Related]
8. Metastatic infectious disease and clinical outcome in Staphylococcus aureus and Streptococcus species bacteremia.
Vos FJ; Kullberg BJ; Sturm PD; Krabbe PFM; van Dijk APJ; Wanten GJA; Oyen WJG; Bleeker-Rovers CP
Medicine (Baltimore); 2012 Mar; 91(2):86-94. PubMed ID: 22391470
[TBL] [Abstract][Full Text] [Related]
9. Septic pulmonary emboli detected by
Méndez-Echevarria A; Coronado-Poggio M; Baquero-Artigao F; Del Rosal T; Rodado-Marina S; Calvo C; Domínguez-Gadea L
Infection; 2017 Oct; 45(5):691-696. PubMed ID: 28243995
[TBL] [Abstract][Full Text] [Related]
10. Predictors of infectious foci on FDG PET/CT in Staphylococcus aureus bacteremia.
Ghanem-Zoubi N; Abu-Elhija J; Kagna O; Mustafa-Hellou M; Qasum M; Haber D; Paul M; Keidar Z
Sci Rep; 2023 Aug; 13(1):14063. PubMed ID: 37640802
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic value of [
Gompelman M; Tuinte R; Aarntzen E; Kouijzer I; van Leerdam E; Berrevoets M; Ten Oever J; Bleeker-Rovers C; Wanten G
Biomed Pharmacother; 2021 Dec; 144():112296. PubMed ID: 34634557
[TBL] [Abstract][Full Text] [Related]
12. Light in the dark:
Colombo J; Elzi L; Treglia G; Perren A
Intensive Care Med; 2018 Apr; 44(4):488-489. PubMed ID: 29134234
[No Abstract] [Full Text] [Related]
13. FDG-PET/CT for Detecting an Infection Focus in Patients With Bloodstream Infection: Factors Affecting Diagnostic Yield.
Pijl JP; Glaudemans AWJM; Slart RHJA; Yakar D; Wouthuyzen-Bakker M; Kwee TC
Clin Nucl Med; 2019 Feb; 44(2):99-106. PubMed ID: 30516689
[TBL] [Abstract][Full Text] [Related]
14. Integration of FDG-PET/CT in the Diagnostic Workup for Staphylococcus aureus Bacteremia: A Prospective Interventional Matched-cohort Study.
Ghanem-Zoubi N; Kagna O; Abu-Elhija J; Mustafa-Hellou M; Qasum M; Keidar Z; Paul M
Clin Infect Dis; 2021 Dec; 73(11):e3859-e3866. PubMed ID: 32639560
[TBL] [Abstract][Full Text] [Related]
15. Head-to-Head Comparison of
Salomäki SP; Kemppainen J; Hohenthal U; Luoto P; Eskola O; Nuutila P; Seppänen M; Pirilä L; Oksi J; Roivainen A
Contrast Media Mol Imaging; 2017; 2017():3179607. PubMed ID: 29114175
[TBL] [Abstract][Full Text] [Related]
16. Positive Impact of [18F]FDG-PET/CT on Mortality in Patients With Staphylococcus aureus Bacteremia Explained by Immortal Time Bias.
van der Vaart TW; Prins JM; van Werkhoven CH; Ten Doesschate T; Soetekouw R; van Twillert G; Veenstra J; Herpers BL; Rozemeijer W; Jansen RR; Bonten MJM; van der Meer JTM
Clin Infect Dis; 2023 Jul; 77(1):9-15. PubMed ID: 36869816
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET/CT in Fever of Unknown Origin, Bacteremia, and Febrile Neutropenia.
Hess S
PET Clin; 2020 Apr; 15(2):175-185. PubMed ID: 32145888
[TBL] [Abstract][Full Text] [Related]
18. The clinical utility of fluorodeoxyglucose-positron emission tomography for investigation of fever in immunocompromised children.
Wang SS; Mechinaud F; Thursky K; Cain T; Lau E; Haeusler GM
J Paediatr Child Health; 2018 May; 54(5):487-492. PubMed ID: 29235187
[TBL] [Abstract][Full Text] [Related]
19. 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan for monitoring the therapeutic response in experimental Staphylococcus aureus foreign-body osteomyelitis.
Chatziioannou S; Papamichos O; Gamaletsou MN; Georgakopoulos A; Kostomitsopoulos NG; Tseleni-Balafouta S; Papaparaskevas J; Walsh TJ; Pneumaticos SG; Sipsas NV
J Orthop Surg Res; 2015 Aug; 10():132. PubMed ID: 26306506
[TBL] [Abstract][Full Text] [Related]
20. [18F]FDG-PET/CT in Staphylococcus aureus bacteremia: a systematic review.
Buis DTP; Sieswerda E; Kouijzer IJE; Huynh WY; Burchell GL; Berrevoets MAH; Prins JM; Sigaloff KCE
BMC Infect Dis; 2022 Mar; 22(1):282. PubMed ID: 35331165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
